Journals / Mikrobiyoloji Bülteni / 2007 / Cilt: 41 - Sayı: 4

Enterococcus spp:Colonized in the gastrointestinal tract of patients in hemato-oncology and intensive care ünits and their resistance profiles to vancomycin

Yğun bakım ve onkolojl-hematoloji hastalarında gastrointestinal sistemde kolonize olan enterokok türleri ve vankomisine direnç profilleri

Pages
585–589
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In conclusion, in order to detect and prevent the spread of VRE, surveillance cultures should be regularly performed from hospitalized patients, in collaboration with educational studies for hospital personel, controlling the use of vancomycin and cephalosporins and cooperation between microbiology laboratories and inpatient clinics.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The aim of this study was to identify the Enterococcus spp. and to determine their vancomycin-resistance profiles, in the samples collected from the patients who were described as risky groups for vancomycin-resistant enterococcal (VRE) colonization, in scope of a survey study carried out in our hospital for the first time.
📊
Key Findings & Data:Rectal swab samples were taken once in a month from a total of 180 patients who were hospitalized in the Surgery and Intensive Care Units, adult Oncology-Hematology and Pediatric Oncology Units between March - December 2006.
💡
Conclusion & Impact:In conclusion, in order to detect and prevent the spread of VRE, surveillance cultures should be regularly performed from hospitalized patients, in collaboration with educational studies for hospital personel, controlling the use of vancomycin and cephalosporins and cooperation between microbiology laboratories and inpatient clinics.
🔬Design:Survey & Empirical Study
📍Scope:2006 Verileri
⚙️Variables:Domain Parameters

Abstract

The aim of this study was to identify the Enterococcus spp. and to determine their vancomycin-resistance profiles, in the samples collected from the patients who were described as risky groups for vancomycin-resistant enterococcal (VRE) colonization, in scope of a survey study carried out in our hospital for the first time. Rectal swab samples were taken once in a month from a total of 180 patients who were hospitalized in the Surgery and Intensive Care Units, adult Oncology-Hematology and Pediatric Oncology Units between March - December 2006. The samples were cultivated onto bile-esculine agar media, and Miniapi system (bioMerieux, France) was used for the identification at species-level (Rapid ID 32 Strep kit, bioMerieux, France) and for the detection of antimicrobial susceptibilities (ATB Enterococcus kit, bioMerieux, France). MIC levels have been determined by the use of vancomycin E-test (AB Biodisk, Sweden) strips in brain-heart infusion agar (Merck, France). According to the culture results, 126 of the patients (70%) have been found to be colonized with Enterococcus spp. The most frequently isolated species were as follows respectively; E.faecium (42%), E.faecalis (31%), E.avium (12%), E.gallinarum (8%) and E.casseliflavus, (5.6%). Four of the E.faecium strains (3.2%) were found resistant to vancomycin by both automated antibiotic susceptibility test system and E-test (MIC>256 mg/ml). Vancomycin-resistant strains have been identified as being VanA genotypes by polymerase chain reaction. Beta-lactamase production has not been detected in any one of the strains with the use of nitrocephin (Remel, USA) disk. As a result the colonization rates of enterococcal species and VRE were found as 70% and 3.2%, respectively in our patients. Infections with VRE have not been detected in colonized patients during the follow-up period. In conclusion, in order to detect and prevent the spread of VRE, surveillance cultures should be regularly performed from hospitalized patients, in collaboration with educational studies for hospital personel, controlling the use of vancomycin and cephalosporins and cooperation between microbiology laboratories and inpatient clinics.

Özet

Bu çalışmanın amacı, hastanemizde ilk kez yapılan sürveyans çalışması kapsamında, vankomisine dirençli enterokok (VRE) kolonizasyonu için risk grubu olan hastalarda enterokok türlerinin araştırılması ve vankomisine direnç profillerinin belirlenmesidir. Mart-Aralık 2006 tarihleri arasında Cerrahi ve Dahili Yoğun Bakım, erişkin Onkoloji-Hematoloji ve Pediatrik Onkoloji bölümlerinde yatmakta olan toplam 180 hastadan ayda bir kez olmak üzere alınan rektal sürüntü örneklerinin kültürleri safra- eskülin besiyerinde yapılmıştır. İzolatların tür düzeyinde tanımlanması ve antimikrobiyal duyarlılıklarının belirlenmesi, Miniapi (bioMerieux, Fransa) cihazında, sırasıyla Rapid ID 32 Strep (bioMerieux, Fransa) ve ATB Enterococcus (bioMerieux, Fransa) kitleri kullanılarak gerçekleştirilmiştir. MİK düzeyleri, beyin-kalp infüzyon agar (Merck, Fransa) besiyerinde vankomisin E-test (AB Biodisk, İsveç) şeritleri kullanılarak araştırılmıştır. Kültür sonuçlarına göre, 126 (%70) hastanın enterokok türleri ile kolonize olduğu saptanmış, en sık izole edilen türler ise sırasıyla E.faecium (%42), E.faecalis (%31), E.avium (%12), E.gallinarum (%8) ve E.casseliflavus, (%5.6) olarak belirlenmiştir. E.faecium izolatlarından dördü (%3.2) antibiyogram ve E-test sonuçlarına (MİK>256 mg/ml) göre vankomisine dirençli olarak bulunmuş ve polimeraz zincir reaksiyonu ile hepsinin VanA genotipinde oldukları saptanmıştır. Nitrosefin (Remel, ABD) diski ile suşların hiçbirisinde beta-laktamaz üretimi tespit edilmemiştir. Çalışmamızda enterokok ve VRE kolonizasyon oranları sırasıyla %70 ve %3.2 olarak bulunmuş, VRE ile kolonize hastaların takibinde VRE’ye bağlı enfeksiyon ortaya çıkmamıştır. Sonuç olarak, hastane ortamında VRE yayılımının engellenmesi için merkezlerde sürveyans kültürlerinin düzenli olarak alınması, hastane çalışanlarına gerekli eğitimin verilmesi, vankomisin ve sefalosporin kullanımının kontrol altına alınması ve mikrobiyoloji laboratuvarı ile servisler arasında iyi bir işbirliğinin sağlanması gereklidir.

🔖

Cite This Article

MENTEŞ, Ö., BALCI, İ. (2007). Enterococcus spp:Colonized in the gastrointestinal tract of patients in hemato-oncology and intensive care ünits and their resistance profiles to vancomycin. Mikrobiyoloji Bülteni, Cilt: 41 - Sayı: 4, 585–589. https://ajindex.com/articles/299386

References (15)

  1. Arıkan Ö. Enterokok türlerinin mikrobiyolojisi, s: 5-9. Çetinkaya Y (ed), Yeni ve Yeniden Gündeme Gelen İnfeksiyonlar. Vankomisine Dirençli Enterokoklar. 2004, Bilimsel Tıp Yayınevi, Ankara
  2. Ersoy Y, Bayraktar M, Fırat M, Yağmur M, Durmaz R. Klinik örneklerden izole edilen enterokok suşlarının antibiyotik duyarlılıkları. Ankem Derg 2005; 19: 92-6
  3. Gazi H, Kurutepe S, Sürücüoğlu S, Ecemiş T, Özbakkaloğlu B. Hastane kökenli Enterococcus faecalis ve Enterococcus faecium suşlarında antimikrobiyal direnç. Ankem Derg 2004; 18: 49-52
  4. Başustaoğlu A. Enterokoklarda vankomisin direnci
  5. Antimikrobik Kemoterapi Günleri. Klinik- Laboratuvar Uygulamaları ve Yenilikler. İstanbul 2004. Program ve Özet Kitabı, s: 16-21
  6. Recommendations for the control of vancomycin-resistant enterococcus (VRE). In: Healthcare Facilities in Georgia, with a Focus on Long-Term Care. The Georgia VRE Task Force in conjuction with The Division of Public Health Georgia Department of Human Resources. February 1998
  7. Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committe (HICPAC). MMWR Recomm Rep 1995; 44 (RR-12): 1-13
  8. De Lisle S, Perl TM. Vancomycin-resistant enterococci: a road map on how to prevent the emergence and transmission of antimicrobial resistance. Chest 2003; 123: S504-18
  9. Gültekin M, Günseren F. Vankomisin dirençli enterokoklar. Hastane Enfeksiyonları Derg 2000; 4: 195-204
  10. Dan M, Poch F, Leibson L, et al. Rectal colonization with vancomycin-resistant enterococci among high risk patients in Israeli hospital. J Hosp Infect 1999; 43: 231-38
  11. Ostrowsky BE, Venkataraman L, D’Agata EMC, et al. Vancomycin-resistant enterococci in intensive care units. Arch Intern Med 1999; 159: 1467-72
  12. Sümerkan B. Vankomisine dirençli enterokoklar, s: 329-34. Sterilizasyon, Dezenfeksiyon ve Hastane İnfeksiyonları. Samsun Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Araştırmaları Derneği, 2002. Samsun
  13. Endtz HP, van den Braak N, van Belkum A, et al. Fecal carriage of vancomycin-resistant enterococci in hospitalized patients and those living in the community in the Netherlands. J Clin Microbiol 1997; 35: 3026-31
  14. Kolar M, Pantucek R, Vagnerova I, et al. Prevalence of vancomycin-resistant enterococci in hospitalized patients and those living in the community in the Czech Republic. New Microbiol 2006; 29: 121-5
  15. Ulusoy S. Yoğun bakım ünitesinde gram-pozitif mikroorgan